Expand ALDX Menu
ALDX MENU

ALDX Latest Press Releases

-- November 13, 2025 --

Aldeyra Therapeutics Announces Expansion of RASP Platform to Include Central Nervous System Diseases and Provides Updates on Reproxalap at Research & Development Webcast Business Wire 7:00 AM

-- November 11, 2025 --

Aldeyra Therapeutics to Participate in the Jefferies Global Healthcare Conference in London Business Wire 7:01 AM

-- November 6, 2025 --

Aldeyra Therapeutics to Host Research & Development Update Webcast Event Scheduled for Thursday, November 13 at 8:00 a.m. ET Business Wire 7:00 AM

-- October 28, 2025 --

Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules Business Wire 7:01 AM

-- September 3, 2025 --

Aldeyra Therapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference Business Wire 7:01 AM

-- August 28, 2025 --

Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Primary Large B-Cell Lymphomas of Immune-Privileged Sites, including Primary Vitreoretinal Lymphoma Business Wire 7:01 AM

-- August 19, 2025 --

Aldeyra Therapeutics Receives Fast Track Designation for ADX-2191 for the Treatment of Retinitis Pigmentosa Business Wire 7:01 AM

-- August 6, 2025 --

Aldeyra Therapeutics to Participate in the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference Business Wire 7:01 AM

-- July 24, 2025 --

Aldeyra Therapeutics Receives Orphan Designation From European Medicines Agency For ADX-2191 In Treatment Of Inherited Retinal Dystrophies Including Retinitis Pigmentosa Benzinga Newsdesk 7:06 AM
Aldeyra Therapeutics Receives Orphan Designation from the European Medicines Agency for ADX-2191 for the Treatment of Inherited Retinal Dystrophies including Retinitis Pigmentosa Business Wire 7:00 AM

-- July 17, 2025 --

Aldeyra Therapeutics Announces FDA Acceptance for Review of Reproxalap New Drug Application for the Treatment of Dry Eye Disease Business Wire 7:00 AM
Market Data Delayed 15 Minutes